In a study on NSCLC, ZEB2 expression was upregulated in metastatic NSCLC tissues, while knockdown of this biomarker could hinder NSCLC cell migration and invasion[74]. The gene discussed is ZEB2; the disease is non-small cell lung carcinoma.